Rich Barron

1.9k total citations
38 papers, 1.4k citations indexed

About

Rich Barron is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Rich Barron has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Surgery and 11 papers in Genetics. Recurrent topics in Rich Barron's work include Neutropenia and Cancer Infections (19 papers), Blood disorders and treatments (11 papers) and Chemotherapy-related skin toxicity (8 papers). Rich Barron is often cited by papers focused on Neutropenia and Cancer Infections (19 papers), Blood disorders and treatments (11 papers) and Chemotherapy-related skin toxicity (8 papers). Rich Barron collaborates with scholars based in United States, Switzerland and Canada. Rich Barron's co-authors include Derek Weycker, Gary H. Lyman, John Edelsberg, Alex Kartashov, Gerry Oster, Matthew W. Reynolds, Jingbo Yu, Daria B. Crittenden, David Chandler and Andreas Grauer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Rich Barron

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rich Barron United States 21 798 339 253 246 206 38 1.4k
Pekka Riikonen Finland 23 744 0.9× 158 0.5× 227 0.9× 152 0.6× 185 0.9× 72 1.8k
J. Roger Hollister United States 9 165 0.2× 86 0.3× 313 1.2× 145 0.6× 100 0.5× 18 1.1k
Yoshihiko Soga Japan 20 274 0.3× 101 0.3× 77 0.3× 92 0.4× 217 1.1× 53 1.4k
Ben Kang South Korea 23 412 0.5× 657 1.9× 229 0.9× 353 1.4× 526 2.6× 111 1.8k
Ulrike John Germany 22 154 0.2× 193 0.6× 85 0.3× 212 0.9× 161 0.8× 40 1.7k
Douglas D Damm United States 26 362 0.5× 83 0.2× 63 0.2× 466 1.9× 87 0.4× 100 1.6k
Françoise Mazingue France 22 267 0.3× 80 0.2× 13 0.1× 131 0.5× 140 0.7× 63 1.4k
M Bardare Italy 17 97 0.1× 117 0.3× 100 0.4× 138 0.6× 105 0.5× 51 863
Luisa Álvarez Spain 21 387 0.5× 65 0.2× 349 1.4× 198 0.8× 277 1.3× 48 1.6k
Glenn W. Geelhoed United States 22 370 0.5× 151 0.4× 29 0.1× 615 2.5× 347 1.7× 87 1.8k

Countries citing papers authored by Rich Barron

Since Specialization
Citations

This map shows the geographic impact of Rich Barron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rich Barron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rich Barron more than expected).

Fields of papers citing papers by Rich Barron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rich Barron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rich Barron. The network helps show where Rich Barron may publish in the future.

Co-authorship network of co-authors of Rich Barron

This figure shows the co-authorship network connecting the top 25 collaborators of Rich Barron. A scholar is included among the top collaborators of Rich Barron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rich Barron. Rich Barron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barron, Rich, Gerry Oster, Andreas Grauer, Daria B. Crittenden, & Derek Weycker. (2020). Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporosis International. 31(11). 2103–2111. 91 indexed citations
2.
Fujiwara, Saeko, Akimitsu Miyauchi, Adèle Weston, et al.. (2018). Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review. Archives of Osteoporosis. 13(1). 34–34. 19 indexed citations
3.
Berry, Sarah D., Alyssa B. Dufour, Thomas G. Travison, et al.. (2018). Changes in bone mineral density (BMD): a longitudinal study of osteoporosis patients in the real-world setting. Archives of Osteoporosis. 13(1). 124–124. 8 indexed citations
4.
Weycker, Derek, John Edelsberg, Rich Barron, et al.. (2017). Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures. Osteoporosis International. 28(9). 2565–2571. 27 indexed citations
5.
6.
Weycker, Derek, Xiaoyan Li, Rich Barron, et al.. (2015). Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice. Supportive Care in Cancer. 24(6). 2481–2490. 13 indexed citations
7.
Fine, Shai, Malcolm Koo, Talvinder Gill, et al.. (2014). The Use of Granulocyte Colony–Stimulating Factors in a Canadian Outpatient Setting. Current Oncology. 21(2). 229–240. 5 indexed citations
8.
Weycker, Derek, Xiaoyan Li, John Edelsberg, et al.. (2014). Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens. Supportive Care in Cancer. 22(12). 3275–3285. 18 indexed citations
9.
Maschio, Michael, Rich Barron, Milton C. Weinstein, et al.. (2013). Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients. Value in Health. 16(3). A140–A140.
10.
Weycker, Derek, John Edelsberg, Alex Kartashov, Rich Barron, & Gary H. Lyman. (2012). Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer. Chemotherapy. 58(1). 8–18. 35 indexed citations
11.
Barron, Rich, et al.. (2012). Costs Associated with Febrile Neutropenia in the US. PharmacoEconomics. 30(9). 809–823. 59 indexed citations
12.
Weycker, Derek, Jennifer L. Malin, Rich Barron, et al.. (2011). Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy. American Journal of Clinical Oncology. 35(3). 267–274. 56 indexed citations
13.
Lyman, Gary H., et al.. (2010). Risk of mortality in patients with cancer who experience febrile neutropenia. Cancer. 116(23). 5555–5563. 184 indexed citations
14.
Weycker, Derek, Jennifer L. Malin, John Kim, et al.. (2009). Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: A retrospective cohort study. Clinical Therapeutics. 31(5). 1069–1081. 61 indexed citations
15.
Campbell, Ulka B., et al.. (2008). Survey Assessment of Continuation of and Satisfaction with Pharmacological Treatment for Urinary Incontinence. Value in Health. 11(4). 726–732. 31 indexed citations
16.
Hershman, Dawn L., et al.. (2008). Patients' Perceptions of Physician‐Patient Discussions and Adverse Events with Cancer Therapy. PubMed. 1(2). 70–78. 12 indexed citations
17.
Chapman, Mary Ann, et al.. (2007). Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia. Clinical Therapeutics. 29(7). 1325–1337. 41 indexed citations
18.
Gordon, Mark Forrest & Rich Barron. (2006). Effectiveness of Repeated Treatment with Botulinum Toxin Type A Across Different Conditions. Southern Medical Journal. 99(8). 853–861. 18 indexed citations
19.
Freitag, Fred, Chris M Kozma, Terra Slaton, Jane T. Osterhaus, & Rich Barron. (2005). Characterization and Prediction of Emergency Department Use in Chronic Daily Headache Patients. Headache The Journal of Head and Face Pain. 45(7). 891–898. 22 indexed citations
20.
Smith, Beth Paterson, et al.. (2003). Recurrence of equinus foot deformity in cerebral palsy patients following surgery: a review.. PubMed. 12(3). 125–33, quiz 134. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pekka Riikonen Breakdown of academic impact, for papers by J. Roger Hollister Breakdown of academic impact, for papers by Yoshihiko Soga Breakdown of academic impact, for papers by Ben Kang Breakdown of academic impact, for papers by Ulrike John Breakdown of academic impact, for papers by Douglas D Damm Breakdown of academic impact, for papers by Françoise Mazingue Breakdown of academic impact, for papers by M Bardare Breakdown of academic impact, for papers by Luisa Álvarez Breakdown of academic impact, for papers by Glenn W. Geelhoed
Rankless by CCL
2026